Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIVOLUMAB vs NOREPINEPHRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIVOLUMAB vs NOREPINEPHRINE: Safety Overview

Metric NIVOLUMAB NOREPINEPHRINE
Total FAERS Reports 87,742 5,103
Deaths Reported 23,086 1,673
Death Rate 26.3% 32.8%
Hospitalizations 36,530 2,668
Average Patient Age 64.2 yrs 57.9 yrs
% Female Patients 34.0% 33.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer E.R. Squibb & Sons, L.L.C. Civica, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription